These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 4324940

  • 1. Conversion of angiotensin I to angiotensin II in peripheral vascular beds of the rat.
    Kreye VA, Gross F.
    Am J Physiol; 1971 May; 220(5):1294-6. PubMed ID: 4324940
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary activation of synthetic angiotensin I.
    Biron P, Huggins CG.
    Life Sci; 1968 Sep 01; 7(17):965-70. PubMed ID: 4309815
    [No Abstract] [Full Text] [Related]

  • 3. Escape of intestinal resistance vessels to angiotensin II.
    McNeill JR.
    Can J Physiol Pharmacol; 1974 Jun 01; 52(3):458-64. PubMed ID: 4368694
    [No Abstract] [Full Text] [Related]

  • 4. Pressor effects of angiotensin infusions into different vascular beds in the rabbit.
    Akinkugbe OO, Brown WC, Cranston WI.
    Clin Sci; 1966 Jun 01; 30(3):409-16. PubMed ID: 4288057
    [No Abstract] [Full Text] [Related]

  • 5. Conversion of angiotensin I in pulmonary and systemic vascular beds of children.
    Friedli B, Biron P, Fouron JC, Davignon A.
    Acta Paediatr Scand; 1974 Jan 01; 63(1):17-22. PubMed ID: 4364448
    [No Abstract] [Full Text] [Related]

  • 6. In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat.
    Freer RJ, Stewart JM.
    Arch Int Pharmacodyn Ther; 1975 Sep 01; 217(1):97-109. PubMed ID: 172037
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of the central pressor action of angiotensin II in conscious rats.
    Lappe RW, Brody MJ.
    Am J Physiol; 1984 Jan 01; 246(1 Pt 2):R56-62. PubMed ID: 6696102
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS, Ferrario CM, Khosla MC, Bumpus FM.
    J Pharmacol Exp Ther; 1973 Apr 01; 185(1):35-41. PubMed ID: 4348281
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interplay of vasodilator and vasoconstrictor substances in the femoral arterial bed: identification of the angiotensin cofactor.
    Haas E, Goldblatt H, Lewis L, Gipson EC.
    Lab Invest; 1973 Jan 01; 28(1):1-7. PubMed ID: 4347553
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic efficacy of etoposide injected via carotid artery with angiotensin II-induced hypertension in experimental rat gliomas].
    Ogasawara H, Kiya K, Kurisu K, Hotta T, Mikami T, Sugiyama K, Uozumi T.
    Gan To Kagaku Ryoho; 1991 Mar 01; 18(3):485-7. PubMed ID: 2003744
    [No Abstract] [Full Text] [Related]

  • 15. Central site for pressor action of blood-borne angiotensin in rat.
    Fink GD, Haywood JR, Bryan WJ, Packwood W, Brody MJ.
    Am J Physiol; 1980 Sep 01; 239(3):R358-61. PubMed ID: 7435606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ, Baranowski RL, Kurtzman NA.
    Arch Int Pharmacodyn Ther; 1974 May 01; 209(1):75-9. PubMed ID: 4370454
    [No Abstract] [Full Text] [Related]

  • 18. Regional vascular selectivity of angiotensin II.
    Jackson EK, Herzer WA.
    J Pharmacol Exp Ther; 2001 May 01; 297(2):736-45. PubMed ID: 11303065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.